Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia

Journal of Behavioral Medicine
Dan V BlalockCorrine I Voils

Abstract

Medication nonadherence is a significant clinical problem among individuals taking statins. Poor adherence is often attributable to several reasons, yet most adherence interventions target a single reason. Baseline data were examined from a randomized clinical trial of 236 patients with hyperlipidemia. A latent class analysis was then performed on patients reporting any nonadherence (n = 109). A 4-class solution provided the most optimal fit and differentiation of classes. Class 1 (N = 59, 54%) included patients who reported occasionally forgetting. Class 2 (N = 16, 14%) represented patients who were concerned about side effects. Class 3 (N = 17, 16%) represented patients who reported out-of-routine life events as contributing to nonadherence. Class 4 (N = 17, 16%) represented patients who endorsed a large number reasons indiscriminately. Class membership was almost uniformly unrelated to any patient demographic factors or treatment arm. Each cluster of reasons defining these patients may be best addressed through different intervention strategies.

References

Feb 21, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Joanne ArchambaultAlbert J Banes
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 6, 2008·Expert Opinion on Drug Safety·Evangelos N LiberopoulosMoses S Elisaf
Jun 17, 2009·Circulation·P Michael HoJohn S Rumsfeld
Jun 30, 2009·Methods of Information in Medicine·H HufnagelH Handels
Oct 30, 2009·Epilepsy & Behavior : E&B·Ian BrownMarkus Reuber
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Apr 19, 2012·BMC Health Services Research·Abhijit S Gadkari, Colleen A McHorney
Mar 30, 2013·American Heart Journal·S Dee MelnykHayden B Bosworth
Jul 31, 2013·Frontiers in Pharmacology·Przemyslaw KardasMichal Matyjaszczyk
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
May 24, 2014·Patient Preference and Adherence·Corrine I VoilsWilliam S Yancy
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Robby NieuwlaatR Brian Haynes
Dec 22, 2016·The Cochrane Database of Systematic Reviews·Mieke L van DrielRichard Deichmann
Feb 28, 2017·JAMA Internal Medicine·Niteesh K ChoudhryJessica M Franklin
Oct 11, 2017·Pharmacoepidemiology and Drug Safety·Walid F GelladCorrine I Voils
May 15, 2018·American Heart Journal·Hayden B BosworthEugene Z Oddone
Nov 6, 2018·The American Psychologist·Hayden B BosworthCorrine I Voils
Feb 21, 2019·Journal of Psychosomatic Research·Dan V BlalockCorrine I Voils

❮ Previous
Next ❯

Citations

Sep 5, 2019·International Journal of Bipolar Disorders·M BauerP C Whybrow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.